WHO ICTRP trial

Hypofractionated radiotherapy for the palliation of patients with advanced head…

ACTRN12605000114640 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12605000114640
Public title Hypofractionated radiotherapy for the palliation of patients with advanced head and neck cancer who are unsuitable for an attempt at curative treatment
Scientific title Assessment of quality of life of patients undergoing hypofractionated radiotherapy for the palliation of patients with advanced head and neck cancer who are unsuitable for an attempt at curative treatment
Primary sponsor Dr Sandro Porceddu
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2
Countries Australia
Conditions Advanced head and neck cancer; Advanced head and neck cancer;Cancer - Head and neck
Interventions Hypofractionated radiotherapy, 30 Gray in 5 fractions, optional 6th 5 Gray fraction.
Registration date Sep 8, 2005
Target size 40
Secondary IDs Hypofractionated head and neck study
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations